Biological responses to materials : BiomaterialsANDERSON, James M.Annual review of materials science. 2001, Vol 31, pp 81-110, issn 0084-6600Article

Biodegradation and biocompatibility of PLA and PLGA microspheresANDERSON, James M; SHIVE, Matthew S.Advanced drug delivery reviews. 2012, Vol 64, pp 72-82, issn 0169-409X, 11 p., SUPArticle

Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cellsMCNALLY, Amy K; ANDERSON, James M.Experimental and molecular pathology. 2011, Vol 91, Num 3, pp 673-681, issn 0014-4800, 9 p.Article

Giant cell formation and functionBRODBECK, William G; ANDERSON, James M.Current opinion in hematology. 2009, Vol 16, Num 1, pp 53-61, issn 1065-6251, 9 p.Article

Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulumMCNALLY, Amy K; ANDERSON, James M.Experimental and molecular pathology. 2005, Vol 79, Num 2, pp 126-135, issn 0014-4800, 10 p.Article

Foreign body-type multinucleated giant cell formation is potently induced by α-tocopherol and prevented by the diacylglycerol kinase inhibitor R59022MCNALLY, Amy K; ANDERSON, James M.The American journal of pathology. 2003, Vol 163, Num 3, pp 1147-1156, issn 0002-9440, 10 p.Article

Synopsis for the Yale Workshop on hepatocellular carcinomaANDERSON, James M; KOWDLEY, Kris V.Journal of clinical gastroenterology. 2002, Vol 35, Num 5, pp S152-S153, issn 0192-0790, SUP2Article

β1 and β2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formationMCNALLY, Amy K; ANDERSON, James M.The American journal of pathology. 2002, Vol 160, Num 2, pp 621-630, issn 0002-9440Article

Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gutRAHNER, Christoph; MITIC, Laura L; ANDERSON, James M et al.Gastroenterology (New York, NY. 1943). 2001, Vol 120, Num 2, pp 411-422, issn 0016-5085Article

Effect of strain and strain rate on fatigue-accelerated biodegradation of polyurethaneWIGGINS, Michael J; ANDERSON, James M; HILTNER, Anne et al.Journal of biomedical materials research. 2003, Vol 66A, Num 3, pp 463-475, issn 0021-9304, 13 p.Article

International Symposium on Recent Advances in Drug Delivery SystemsANDERSON, James M; KIM, S. W; KOPECEK, Jindrich et al.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 119-424, issn 0168-3659Conference Proceedings

Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptideHOFMANN, Christopher M; BEDNAR, Kyle J; ANDERSON, James M et al.Journal of biomedical materials research. Part A. 2012, Vol 100, Num 4, pp 1061-1067, issn 1549-3296, 7 p.Article

Polymorphonuclear leukocyte inhibition of monocytes/ macrophages in the foreign body reactionKIRK, James T; MCNALLY, Amy K; ANDERSON, James M et al.Journal of biomedical materials research. Part A. 2010, Vol 94, Num 3, pp 683-687, issn 1549-3296, 5 p.Article

Influence of biomaterial surface chemistry on the apoptosis of adherent cellsBRODBECK, William G; SHIVE, Matthew S; COLTON, Erica et al.Journal of biomedical materials research. 2001, Vol 55, Num 4, pp 661-668, issn 0021-9304Article

Cross-linked high amylose starch for controlled release of drugs : recent advancesLENAERTS, V; MOUSSA, I; DUMOULIN, Y et al.Journal of controlled release. 1998, Vol 53, Num 1-3, pp 225-234, issn 0168-3659Conference Paper

Inhalation delivery systems with compliance and disease management capabilitiesGONDA, I; SCHUSTER, J. A; RUBSAMEN, R. M et al.Journal of controlled release. 1998, Vol 53, Num 1-3, pp 269-274, issn 0168-3659Conference Paper

Targeting tumor cells with bispecific antibodies and T cellsKRANZ, D. M; MANNING, T. C; RUND, L. A et al.Journal of controlled release. 1998, Vol 53, Num 1-3, pp 77-84, issn 0168-3659Conference Paper

(Glyco)-protein drug carriers with an intrinsic therapeutic activity : The concept of dual targetingMEIJER, D. K. F; MOLEMA, G; MOOLENAAR, F et al.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 163-172, issn 0168-3659Conference Paper

Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transportCOLOMBO, P; BETTINI, R; SANTI, P et al.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 231-238, issn 0168-3659, 7 p.Conference Paper

Biodegradable nanoparticles : From sustained release formulations to improved site specific drug deliveryLEROUX, J.-C; ALLEMANN, E; DE JAEGHERE, F et al.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 339-350, issn 0168-3659Conference Paper

Controllable gene therapy. Pharmaceutics of non-viral gene delivery systemsTOMLINSON, E; ROLLAND, A. P.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 357-372, issn 0168-3659Conference Paper

Growth factor release from vascular graftsGREISLER, H. P.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 267-280, issn 0168-3659Conference Paper

Recombinant immunotoxins for the treatment of cancerFITZGERALD, D; PASTAN, I.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 261-266, issn 0168-3659, 5 p.Conference Paper

A novel drug delivery system utilizing a glucose responsive polymer complex between poly (vinyl alcohol) and poly (N-vinyl-2-pyrrolidone) with a phenylboronic acid moietyKITANO, S; KOYAMA, Y; KATAOKA, K et al.Journal of controlled release. 1992, Vol 19, Num 1-3, pp 161-170, issn 0168-3659Conference Paper

Biocompatibility studies of naltrexone sustained release formulationsYAMAGUCHI, K; ANDERSON, J. M.Journal of controlled release. 1992, Vol 19, Num 1-3, pp 299-314, issn 0168-3659Conference Paper